Navigation Links
Velos, Inc. Releases Software to Support Cancer Centers With New Workflow and Content for NCI Clinical Trials Reporting Program
Date:7/16/2009

>

"We at Velos are consistently watchful and alert to all indicators from the NCI regarding new programs to which our cancer center community will need to respond," continued Dr. Sahai. "These registration requirements are important to the NCI and to the industry as a whole because they are an essential, information-gathering initiative. Through this program, the NCI can carry out a prioritization process to more effectively focus resources on trials judged most likely to facilitate advances in treatment. However, they are not without complexity, and they impose a significant new workload on the cancer care and research community. Our effort with this new release of capabilities is to minimize effort and maximize automation in support of the new trial reporting requirements."

CTRP has published specifications and the new Velos eResearch software, with built-in compatibility to these standards, has been released to sites. Customers who would otherwise be burdened by multiple manual, software, and email reporting processes now have a streamlined, single system with one data source, resulting in multiple CTRP-ready outputs. Despite the complexity of the new reporting requirements, all the new content was prepared by Velos teams, using flexible toolkits in the system, with no changes to core code, and no system downtime for customers. Velos customers who have been designated "Early Adopters" of the CTRP are now completing the required registrations and data transfers using the new Velos eResearch functionality.

About the Clinical Trials Reporting Program at the NCI

NCI's new Clinical Trials Reporting Program fulfills a recommendation made by the NCI Clinical Trials Working Group to the National Cancer Advisory Board. The purpose of the program is to establish a comprehensive database containing regularly updated information on all NCI-funded interventional clinical trials. Gra
'/>"/>

SOURCE Velos, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
2. CEL-SCI Corporation Releases Letter to Shareholders
3. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
4. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
5. Immunosyn Corporation Releases SF-1019 Study Results
6. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
7. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
8. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
9. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
10. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
11. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... -- The Mesothelioma Victims Center is incredibly passionate about ... best possible compensation, and they are also extremely focused ... caused by exposure to asbestos or their family ... options such as a recent possible medical breakthrough. For ... anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
(Date:5/22/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/3rthk2/latest ) ... Regulations on Pharmaceutical International Multi-Center Clinical Trials in ... This is first time in history, Chinese pharmaceutical ... clinical trials of drugs in China ... on March 1, 2015. The guidance provides an ...
(Date:5/22/2015)... , May 22, 2015 AcelRx Pharmaceuticals, Inc. ... on the development and commercialization of innovative therapies for ... that interim chief executive officer Howie Rosen ... chief financial officer Tim Morris will be ... the two presentations are as follows: Jefferies ...
Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 52015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2
(Date:5/23/2015)... On Saturday, May 23, 2015, over 100 volunteers ... Florida City exactly five years to the day after the ... A large fire tore through the Branches United Methodist Church ... the middle of the night as neighbors, staff and Branches' ... even though it is suspected that the fire began accidentally. ...
(Date:5/23/2015)... CA (PRWEB) May 23, 2015 Dr. David ... California, has just posted a new article to ... repair. As Dr Benvenuti explained in the fascinating ... enlarged plugs in their earlobes. , Known as “gauging,” the ... earlobe hole, which Dr. Benvenuti said will eventually stretch the ...
(Date:5/23/2015)... May 23, 2015 On Wednesday, May ... “the company has been the target of a sophisticated ... of the company’s ongoing Information Technology (IT) security efforts ... , The most notable attack on health insurers ... Inc., the nation’s second largest health insurer, revealed that ...
(Date:5/23/2015)... 2015 Manufacturers are now required to produce ... of 8.2. Experts in the field agree that the regulation ... The HSPF score is what miles per gallon is to ... unit. Although the minimum HSPF score has been raised to ... HSPF score north of 12. Indeed, the regulation was welcomed ...
(Date:5/23/2015)... Javon Bea Mercy Health System CEO ... Center, 557 N. Washington St., Janesville, will host an ... pm. , The 8-week clinic is lead by Brent ... who will offer training that encompasses a warm-up, training ... show selection and weekly training plans. , The program ...
Breaking Medicine News(10 mins):Health News:Five Years After Fire, Branches Rebuilds Playground 2Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2
... , Health Sector in Vanguard of Clean Energy Programs ... 3 In recent months, three U.S. hospitals signed energy contracts ... them with up to 10 percent clean energy. The green energy will ... is equivalent to taking 2,052 cars off the road or not burning ...
... PEMBROKE , Bermuda , Feb. 3 ... announced today that Theana Iordanou has,joined the company as ... responsible for managing profit & loss for the New York ... to,expand distribution and manage relationships with the brokerage community in,the ...
... levels of an inflammatory chemokine were significantly elevated ... obese, according to research conducted by scientists at ... They presented their data at the 5th Annual ... Studies have shown that obesity is correlated with ...
... cancer survivors live longer, questions arise about what kind of ... study from Case Western Reserve University,s Mandel School of Applied ... had more health problems as compared to a sample of ... Well-Being in Older Married Female Cancer Survivors," was published as ...
... , , ... Frost & Sullivan Ghanaian Pharmaceutical Industry Innovation & Advancement Award ... company to manufacture Active Pharmaceutical Ingredients (APIs). Adhering to Good ... tonnes of API, 8 million laminated aluminum tubes of dermatological ...
... new approach for the care of respiratory diseases report ... associated with improved outcomes in tests on mice with ... human embryonic stem cells (hESCs). Findings by investigators at ... are scheduled to appear in the March issue of ...
Cached Medicine News:Health News:Unique Clean Energy Program Helps Hospitals Buy Clean Energy, Reduce Costs and Counteract Climate Change 2Health News:Unique Clean Energy Program Helps Hospitals Buy Clean Energy, Reduce Costs and Counteract Climate Change 3Health News:Unique Clean Energy Program Helps Hospitals Buy Clean Energy, Reduce Costs and Counteract Climate Change 4Health News:Allied World Appoints Theana Iordanou Vice President and New York Regional Branch Manager 2Health News:Allied World Appoints Theana Iordanou Vice President and New York Regional Branch Manager 3Health News:Older female cancer survivors have added health issues compared to their counterparts 2Health News:Frost & Sullivan Ghanaian Pharmaceutical Industry Innovation & Advancement Award Conferred on LaGray Chemical Company 2Health News:Frost & Sullivan Ghanaian Pharmaceutical Industry Innovation & Advancement Award Conferred on LaGray Chemical Company 3Health News:Frost & Sullivan Ghanaian Pharmaceutical Industry Innovation & Advancement Award Conferred on LaGray Chemical Company 4Health News:Experimental stem cell treatment arrests acute lung injury in mice, study shows 2
... Colorimetric Assay of ... and Low Molecular ... substrate CBS 31.39, ... purified bovine ATIII, ...
Substrate Plasma for Factor V Assay by STA© Analyzers. Freeze-dried human plasma, artificially depleted of factor V....
Substrate Plasma for Factor IX Assay by STA© Analyzers. Freeze-dried human plasma from which factor IX has been removed by selective immuno-adsorption....
Substrate Plasma for Factor XII Assay by STA© Analyzers. Freeze-dried human plasma lacking factor XII....
Medicine Products: